Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 7:10 AM ET

Biotechnology

Company Overview of CuraGen Corporation

Company Overview

CuraGen Corporation develops novel therapeutics for the treatment of cancer in the United States and Europe. The company focuses on the development of CR011-vcMMAE, a Phase II clinical trail drug for the treatment of patients with metastatic melanoma and breast cancer. It has strategic collaborations with Amgen Fremont to develop fully-human monoclonal antibody therapeutics; and Seattle Genetics, Inc. to license Seattle Genetics’ proprietary antibody- drug conjugate technology. The company was incorporated in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.

322 East Main Street

Branford, CT 06405

United States

Founded in 1991

16 Employees

Phone:

203-481-1104

Fax:

203-483-1102

Key Executives for CuraGen Corporation

Chief Financial Officer
Age: 67
Chief Medical Officer
Director of Investor Relations
Executive Director
Age: 60
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
KMS Industries, Inc. United States
Puresyn, Inc. United States
Genetronics Inc. United States
NanoDetection Technology Inc. United States
Verdeca LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CuraGen Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.